-
41
Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs
Published 2025-01-01Get full text
Article -
42
Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis
Published 2025-02-01Get full text
Article -
43
Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort...
Published 2025-01-01“…In subgroup analyses, patients with high IFNGS and high disease activity state (HDAS) at baseline used more immunosuppressants and glucocorticoids compared with those with low IFNGS and non-HDAS at baseline.Conclusions These findings underscore that SLE therapy is still often unable to reach goals as recommended by the European Alliance of Associations for Rheumatology, both with regard to glucocorticoid use and disease activity, suggesting that there is an unmet need for new treatment options for patients with SLE.Trial registration number NCT03189875; 16 June 2017.…”
Get full text
Article -
44
-
45
Author Correction: Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis
Published 2025-02-01Get full text
Article -
46
-
47
Clinical Characteristics and Treatment Options of Peripheral Spondyloarthritis
Published 2024-12-01Get full text
Article -
48
Clinical Features and Prognosis of Double-Positive Anti-MDA5 and Anti-CCP Antibodies in Dermatomyositis: A Retrospective Study
Published 2025-02-01“…Xiayu Xu,1 Longyang Zhu,2 Sizhao Li,3 Guochun Wang,3 Yongpeng Ge3 1Department of Rheumatology and Immunology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, People’s Republic of China; 2Peking University, China-Japan Friendship School of Clinical Medicine, Beijing, People’s Republic of China; 3Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Beijing, People’s Republic of ChinaCorrespondence: Yongpeng Ge, Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Beijing, 100029, People’s Republic of China, Email [email protected]: To investigate the clinical features and prognosis of anti-melanoma differentiation-related gene 5 (MDA5) antibody and anti-cyclic citrullinated peptide (CCP) antibody double-positive dermatomyositis (DM) (MDA5+/CCP+ DM).Methods: A retrospective analysis of 264 consecutive cases of MDA5+ DM hospitalized from March 2018 to March 2022, and patients with anti-CCP antibodies were screened out. …”
Get full text
Article -
49
Distinguishing rheumatoid arthritis from psoriatic arthritis
Published 2018-08-01Get full text
Article -
50
-
51
Editorial: T and B cell immune dynamics in allergic response
Published 2025-02-01Get full text
Article -
52
Plastic deformation of anterior cruciate ligament: listen to the patient, do not just rely on imaging
Published 2025-02-01Get full text
Article -
53
-
54
-
55
Development of quality indicators for hand osteoarthritis care – Results from an European consensus study
Published 2025-03-01Get full text
Article -
56
Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis
Published 2021-11-01Get full text
Article -
57
-
58
-
59
Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
Published 2022-02-01Get full text
Article -
60
Arteritis de células gigantes: actualización diagnóstica y terapéutica
Published 2024-10-01“…Se han tomado como referencia los protocolos diagnósticos y terapéuticos elaborados por el American College of Rheumatology y la European Alliance of Associations for Rheumatology. …”
Get full text
Article